"Long standing Endocrinology practice specializing in Diabetes, Thyroid conditions and Endocrine problems."

During the past decade, Southeastern Endocrine & Diabetes conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southeastern Endocrine & Diabetes" are "Asthma" (1 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetes, Type 1" (1 trials) and "Diabetes, Type 2" (1 trials). Many other conditions were trialed in "Southeastern Endocrine & Diabetes" in a lesser frequency.

Most popular intervention types in "Southeastern Endocrine & Diabetes" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Technosphere Insulin" (1 trials), "Technosphere® Insulin Inhalation Powder" (1 trials) and "Usual Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Endocrine & Diabetes" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Southeastern Endocrine & Diabetes". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Southeastern Endocrine & Diabetes, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Endocrine & Diabetes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".